194 related articles for article (PubMed ID: 11795074)
1. Therapeutic angiogenesis inhibitors in the treatment of cancer.
Hidalgo M; Pierson AS; Holden SN; Bergen M; Eckhardt SG
Adv Intern Med; 2001; 47():159-90. PubMed ID: 11795074
[No Abstract] [Full Text] [Related]
2. [Tumor dormancy therapy for hepatocellular carcinoma].
Hori T; Ido A; Tsubouchi H
Nihon Rinsho; 2001 Oct; 59 Suppl 6():824-8. PubMed ID: 11762064
[No Abstract] [Full Text] [Related]
3. [Therapeutic prospects of angiogenesis inhibitors in cancerology].
Bout JC; Soncin F; Vandenbunder B
Rev Mal Respir; 1999 Nov; 16(5):854-5. PubMed ID: 10612161
[No Abstract] [Full Text] [Related]
4. Anticancer drug targets: approaching angiogenesis.
Keshet E; Ben-Sasson SA
J Clin Invest; 1999 Dec; 104(11):1497-501. PubMed ID: 10587512
[No Abstract] [Full Text] [Related]
5. Advances in the use of angiogenesis inhibitors in cancer.
Pinedo HM
Cancer J; 2001; 7 Suppl 3():S107-8. PubMed ID: 11779080
[No Abstract] [Full Text] [Related]
6. [Anti-angiogenic reagents].
Shibuya M
Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):1182-7. PubMed ID: 10771693
[No Abstract] [Full Text] [Related]
7. [Antiangiogenic therapy].
Toi M
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2003-9. PubMed ID: 9838900
[TBL] [Abstract][Full Text] [Related]
8. Bioimmunotherapeutic targets on angiogenetic blood vessels in solid malignangies.
Maio M; Altomonte M; Calabro L; Fonsatti E
Front Biosci; 2001 Jun; 6():D776-84. PubMed ID: 11401781
[TBL] [Abstract][Full Text] [Related]
9. Angiogenesis and antiangiogenic therapy.
Sledge GW; Miller KD
Curr Probl Cancer; 2002; 26(1):1-60. PubMed ID: 11961506
[No Abstract] [Full Text] [Related]
10. [Angiogenesis research--quo vadis?].
Augustin HG
Ophthalmologe; 2003 Feb; 100(2):104-10. PubMed ID: 12589453
[TBL] [Abstract][Full Text] [Related]
11. [Progress in diagnosis and treatment of lung cancer].
Fukuoka M
Nihon Naika Gakkai Zasshi; 2002 Mar; 91 Suppl():15-22. PubMed ID: 11989256
[No Abstract] [Full Text] [Related]
12. [Research on the endothelium and new therapeutic strategies in tumors and cardiovascular diseases].
Dejana E
Recenti Prog Med; 1999 Feb; 90(2):64-8. PubMed ID: 10208094
[No Abstract] [Full Text] [Related]
13. Angiogenesis inhibitors in the treatment of lung cancer.
Sun S; Schiller JH
Crit Rev Oncol Hematol; 2007 May; 62(2):93-104. PubMed ID: 17306557
[TBL] [Abstract][Full Text] [Related]
14. General aspects of anti-angiogenesis and cancer therapy.
Zogakis TG; Libutti SK
Expert Opin Biol Ther; 2001 Mar; 1(2):253-75. PubMed ID: 11727534
[TBL] [Abstract][Full Text] [Related]
15. A targeted approach for antiangiogenic therapy of metastatic human colon cancer.
Ellis LM
Am Surg; 2003 Jan; 69(1):3-10. PubMed ID: 12575772
[TBL] [Abstract][Full Text] [Related]
16. [Progress in the lung cancer therapy with angiogenesis inhibitors].
Bai C; Ma T
Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):306-7. PubMed ID: 11326959
[No Abstract] [Full Text] [Related]
17. [Angiogenesis and metastasis in colorectal cancer].
Yamada K; Yamamura T; Yamaguchi S
Nihon Rinsho; 2003 Sep; 61 Suppl 7():97-101. PubMed ID: 14574863
[No Abstract] [Full Text] [Related]
18. The clinical implications of angiogenesis in the treatment of cancer.
Aoun E; Taher A
J Med Liban; 2002; 50(1-2):32-8. PubMed ID: 12841311
[TBL] [Abstract][Full Text] [Related]
19. [Research on the antimetastatic agents].
Takeshima H
Nihon Rinsho; 2005 Sep; 63 Suppl 9():79-85. PubMed ID: 16201504
[No Abstract] [Full Text] [Related]
20. [The clinical perspective of angiogenesis inhibitors].
Radema SA; Witteveen PO; Gebbink MB; Voest EE
Ned Tijdschr Geneeskd; 2003 Aug; 147(35):1675-80. PubMed ID: 14513538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
